• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Embolism from the heart or the thoracic aorta often leads to clinically significant morbidity
and mortality due to transient ischemic attack, stroke or occlusion of peripheral arteries …

Numerous types of cancer have been shown to be associated with either ischemic or
hemorrhagic stroke. In this review, the epidemiology and pathophysiology of stroke in …

Thromboembolism is considered to have a substantial impact on outcomes in patients with
cancer. Although progress in cancer therapy and the advent of new anticancer agents such …

Objective: To determine the cumulative rate and characteristics of recurrent thromboembolic
events after acute ischemic stroke in patients with cancer. Methods: We retrospectively …

Background Nonbacterial thrombotic endocarditis, or marantic endocarditis, is rare.
Contemporary data on the etiology, echocardiographic evaluation, and management of …

The interrelationship between stroke and cancer is complex. Cancer and stroke may occur
independently in a given patient, or cancer may directly or indirectly lead to stroke via …

Cardio-Oncology is a rapidly growing sub-specialty of medicine, however, there is very
limited guidance on the use of cardiac CT (CCT) in the care of Cardio-Oncology patients. In …

Nonbacterial thrombotic endocarditis (NBTE), formerly known as marantic endocarditis, is a
potentially overlooked condition that involves the formation of sterile, fibrin vegetations on …

Cancer patients and survivors have elevated cardiovascular risk when compared with
noncancer patients. Cardio-oncology has emerged as a new subspecialty to comanage and …